Pharmaceutical Biocatalysis: Drugs, Genetic Diseases, and Epigenetics, 1st Edition (Hardback) book cover

Pharmaceutical Biocatalysis

Drugs, Genetic Diseases, and Epigenetics, 1st Edition

Edited by Peter Grunwald

Jenny Stanford Publishing

500 pages

Purchasing Options:$ = USD
Hardback: 9789814877145
pub: 2020-07-31
Available for pre-order. Item will ship after 31st July 2020
$500.00
x


FREE Standard Shipping!

Description

Volume 7 of the Jenny Stanford Series on Biocatalysis deals with several different aspects of pharmaceuticals, which include not only various applications of drugs and their metabolism but also natural resources for active pharmaceutical ingredients as well as the removal of pharmaceutical pollution. In detail, novel approaches for developing microbial fermentation processes to produce vitamin B6 using microorganisms are described together with novel routes for vitamin B6 biosynthesis. The other topics discussed are new approaches for producing the successful anticancer drug Taxol from naturally occurring precursors, molecular farming through plant engineering as a cost-effective means to produce therapeutic and prophylactic proteins, and successful screening of potent microorganisms producing L-asparaginase for various chemotherapeutic applications. Furthermore, microbial biotransformations in the production and degradation of fluorinated pharmaceuticals are described. The other chapters inform the reader about the biotransformation of xenobiotics/drugs in living systems, the degradation of pharmaceuticals by white-rot fungi and their ligninolytic enzymes, and the removal of pharmaceutical pollution from municipal sewage using laccase.

Table of Contents

Fermentative Production of Vitamin B6

Jonathan Rosenberg, Björn Richts, and Fabian M. Commichau

Exploring Alternative Taxol Sources: Biocatalysis of 7-β-Xylosyl-10-Deacetyltaxol and Application for Taxol Production

Wan-Cang Liu et al.

Molecular Farming through Plant Engineering: A Cost Effective Approach to Produce Therapeutic and Prophylactic Proteins

Prakash Narayana Reddy, Krupanidhi Srirama, and Vijaya R. Dirisala

Microbial Biotransformations in the Production and Degradation of Fluorinated Pharmaceuticals

Cormac D. Murphy and Aoife Phelan

Successful Screening of Potent Microorganisms Producing L-Asparaginase

Archana Vimal and Awanish Kumar

Biotransformation of Xenobiotics in Living Systems

Maja Đanić and Momir Mikov

Degradation of Pharmaceutically Active Compounds by White-Rot Fungi and Their Ligninolytic Enzymes

Muhammad B. Asif and Faisal I. Hai

Removal of Pharmaceutical Pollutions from Municipal Sewage Mediated by Laccases

Thomas Hahn et al.

Mechanism of Drug Resistance in Staphylococcus aureus and Future Drug Discovery

Ana Leticia Gori Lusa et al.

Genome Editing and Gene Therapies: Complex and Expensive Drugs

Peter Grunwald

Epigenetic and Metabolic Alterations in Cancer Cells: Mechanisms and Therapeutic Approaches

Chi Chun Wong and Jun Yu

About the Editor

Peter Grunwald studied chemistry at the Universities of Saarbrücken and Hamburg, Germany. He graduated in the field of high-frequency spectroscopy and then became a staff member of the Institute of Physical Chemistry. After receiving his PhD in physical chemistry, he founded a biotechnology research group. He was appointed professor in 2001.

About the Series

Jenny Stanford Series on Biocatalysis

Learn more…

Subject Categories

BISAC Subject Codes/Headings:
MED009000
MEDICAL / Biotechnology
MED072000
MEDICAL / Pharmacy
SCI010000
SCIENCE / Biotechnology
SCI013000
SCIENCE / Chemistry / General
SCI013060
SCIENCE / Chemistry / Industrial & Technical
SCI086000
SCIENCE / Life Sciences / General